FREE Email Newsletter Bioscience Technology Daily

Amyloid – an abnormal protein whose accumulation in the brain is a hallmark of Alzheimer’s disease – starts accumulating inside neurons of people as young as 20, a much younger age than scientists ever imagined, reports a surprising new study.

March 3, 2015 4:29 pm |
by Pete Farley, University of California San Francisco |
Comments

Tumor recurrence following a period of remission is the main cause of death in cancer. The ability of cancer cells to remain dormant during and following therapy, only to be reactivated at a later time, frequently with greater aggressiveness, is one of the least-understood aspects of the disease.

The prevailing medical wisdom that Alzheimer's Disease has its origins in the brain has a radical and disputed rival with shocking implications for medicine's relentless efforts to forestall disease, ageing and death, according to a new review of the evidence.

Highlighting a potential target in the treatment of multiple sclerosis (MS) and Alzheimer’s disease, new research suggests that triggering a protein found on the surface of brain cells may help slow the progression of these and other neurological diseases.